These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2768993)

  • 21. The influence of oral contraceptives on the composition of bile.
    Brockerhoff P; Höckel M; Holtermüller KH; Köhl M; Weis HJ; Rathgen GH
    Klin Wochenschr; 1982 Feb; 60(3):153-7. PubMed ID: 7078021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Menstrual regulation by sequential hormone therapy.
    Beaton JH
    West J Surg Obstet Gynecol; 1964; 72():160-3. PubMed ID: 12332438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral contraceptives, lipoproteins, and atherosclerosis.
    Adams MR; Clarkson TB; Shively CA; Parks JS; Kaplan JR
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1388-93. PubMed ID: 2220963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral contraceptives and their influence on porphyrin concentrations in erythrocytes and urine.
    Kansky A; Gregorc J; Pavlic M
    Dermatologica; 1978; 157(3):181-5. PubMed ID: 680302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Anovlar in gynaecological disorders and contraception.
    Shahani SM; Chiklikar A
    J Obstet Gynaecol India; 1968 Apr; 18(2):592-7. PubMed ID: 12331827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steroid excretion in users of the injectable combined oestrogen progestogen preparation, deladroxate.
    Zaki K; Younis N; Nour H
    Egypt Popul Fam Plann Rev; 1971 Dec; 4(2):1-5. PubMed ID: 12255961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
    Scott JZ; Kletzky OA; Brenner PF; Mishell DR
    Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of high-dose estrogens versus low-dose ethinylestradiol and norgestrel combination in postcoital interception: a study in 493 women.
    Van Santen MR; Haspels AA
    Fertil Steril; 1985 Feb; 43(2):206-13. PubMed ID: 3881294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of ethinylestradiol and mestranol in sequential-type oral contraceptives in their effects on blood glucose and serum insulin in oral glucose tolerance tests.
    Leis D; Botterman P; Ermler R; Maurer U
    Fertil Steril; 1977 Jul; 28(7):737-40. PubMed ID: 872954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The varying effects of progestins on lipid levels and cardiovascular disease.
    La Rosa JC
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1621-9. PubMed ID: 3132043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Problems in evaluating chronic toxicity of contraceptive steroids in dogs.
    Weikel JH; Nelson LW
    J Toxicol Environ Health; 1977 Sep; 3(1-2):167-77. PubMed ID: 72828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple arterial occlusions and hypertension probably caused by an oral contraceptive: a patient in whom the development of renovascular hypertension has been followed.
    Delin K; Aurell M; Claes G; Teger-Nilsson AC; Wallentin I
    Clin Nephrol; 1976 Oct; 6(4):453-7. PubMed ID: 788979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic testing of hypothalamic-pituitary function in abnormalities of ovulation.
    Jones GE; Wentz AC; Rosenwaks Z; Shoemaker J
    Am J Obstet Gynecol; 1977 Dec; 129(7):760-76. PubMed ID: 343592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of panic disorder induced by oral contraceptive.
    Ushiroyama T; Okamoto Y; Toyoda K; Sugimoto O
    Acta Obstet Gynecol Scand; 1992 Jan; 71(1):78-80. PubMed ID: 1315108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
    Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pill-a-month as an oral contraceptive.
    Hefnawi F; Hassanein M; Younis N
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pituitary and ovarian responsiveness to a graded gonadotropin releasing factor stimulation test in women using a low-estrogen or a regular type of oral contraceptive.
    Spellacy WN; Kalra PS; Buhi WC; Birk SA
    Am J Obstet Gynecol; 1980 May; 137(1):109-15. PubMed ID: 6768295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant hypertension and antiphospholipid antibodies as presenting features of SLE in a young woman using oral contraceptives.
    Julkunen H; Kaaja R; Jouhikainen T; Teppo AM; Friman C
    Br J Rheumatol; 1991 Dec; 30(6):471-2. PubMed ID: 1747706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.